SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today introduced SureVector, the world's first modular vector kit for researchers involved in molecular cloning and DNA assembly.
Since acquiring Stratagene in 2007, Agilent has been a leading provider of molecular biology tools and is one of the few companies that offer a set of products that address the entire workflow for molecular and synthetic biology.
Harnessing the efficiency of next-generation DNA assembly technologies, SureVector provides a synthetic biology-based approach to creating vectors from small fragments of DNA that include the features to make these vectors functional in a variety of cell types.
'SureVector enables biologists to quickly, efficiently and reliably construct customized vectors [small DNA molecules within cells that can replicate independently] from standard components,' said Jacob Thaysen, president of Agilent's Diagnostics and Genomics Group. 'It will change the way people think about and do molecular cloning.'
Laboratories that rely on service providers to create custom vectors often pay high per-unit costs and must endure long lead times. The alternative, ordering DNA fragments and assembly enzymes separately, leaves the lab to toil with DNA/enzyme combinations that have not been validated and may require extensive troubleshooting.
With SureVector, on the other hand, Agilent provides an extensively validated set of standardized parts that can be assembled into thousands of combinations covering a huge portion of commercially available vectors.
'As a result, labs will be able to design, create and use a new custom vector in less than a day, rather than the two weeks it often takes today,' Thaysen said. 'What's more, SureVector offers extraordinary flexibility at less than a third of the average per-unit price of custom vectors.'
This new product is part of Agilent's cutting-edge synthetic biology product line, which includes both the highest-fidelity DNA synthesis platform and advanced measurement instruments such as mass spectrometry systems. SureVector follows QuikChange HT and the SureGuide CRISPR/Cas system as the latest in a series of next-generation tools for the molecular and synthetic biology community.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services, and consumables for the entire laboratory workflow. Agilent generated revenues of $4.0 billion in fiscal 2014. The company employs about 12,000 people worldwide. Information about Agilent is available at www.agilent.com.